Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.59 is 69% above its 5-year average of -1.90, near the high end of its 5-year range (-5.37–-0.35).
36.90% above its 12-month average of -0.94.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.14.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 28 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.59
EARNINGS PER SHARE (EPS) AVG TTM
-0.94
EARNINGS PER SHARE (EPS) AVG 3Y
-1.38
EARNINGS PER SHARE (EPS) AVG 5Y
-1.90
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+36.90%
CURRENT VS 3Y AVG
+57.17%
CURRENT VS 5Y AVG
+68.97%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
10x Genomics, Inc.
Market Cap
$10.24B
Earnings Per Share (EPS)
-0.59
TTM Avg
-0.94
3Y Avg
-1.38
5Y Avg
-1.90
Market Cap
$10.19B
Earnings Per Share (EPS)
0.19
TTM Avg
14.72
3Y Avg
15.46
5Y Avg
14.11
Market Cap
$10.31B
Earnings Per Share (EPS)
3.89
TTM Avg
2.37
3Y Avg
1.93
5Y Avg
1.71
Market Cap
$10.15B
Earnings Per Share (EPS)
-0.97
TTM Avg
-0.48
3Y Avg
-0.79
5Y Avg
-0.77
Market Cap
$10.13B
Earnings Per Share (EPS)
5.76
TTM Avg
5.64
3Y Avg
5.43
5Y Avg
9.01
Market Cap
$10.40B
Earnings Per Share (EPS)
-2.22
TTM Avg
-2.45
3Y Avg
-3.14
5Y Avg
-3.21
Market Cap
$10.03B
Earnings Per Share (EPS)
6.38
TTM Avg
5.63
3Y Avg
4.78
5Y Avg
4.31
Market Cap
$9.93B
Earnings Per Share (EPS)
8.25
TTM Avg
-18.74
3Y Avg
-45.28
5Y Avg
14.90
Market Cap
$9.87B
Earnings Per Share (EPS)
0.73
TTM Avg
0.20
3Y Avg
1.10
5Y Avg
1.31
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 10x Genomics, Inc. (TXG) | $10.24B | -0.59 | -0.94 | -1.38 | -1.90 |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | 0.19 | 14.72 | 15.46 | 14.11 |
| Globus Medical, Inc. (GMED)vs › | $10.31B | 3.89 | 2.37 | 1.93 | 1.71 |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | -0.97 | -0.48 | -0.79 | -0.77 |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 5.76 | 5.64 | 5.43 | 9.01 |
| Twist Bioscience Corporation (TWST)vs › | $10.40B | -2.22 | -2.45 | -3.14 | -3.21 |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 6.38 | 5.63 | 4.78 | 4.31 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 8.25 | -18.74 | -45.28 | 14.90 |
| Repligen Corporation (RGEN)vs › | $9.87B | 0.73 | 0.20 | 1.10 | 1.31 |
| Universal Health Services, Inc. (UHS)vs › | $10.72B | 24.38 | 20.29 | 15.04 | 13.87 |
Trailing EPS (TTM)
$-0.59
Forward EPS (Est.)
$-0.74
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.35 |
| 2024-12-31 | -1.52 |
| 2023-12-31 | -2.18 |
| 2022-12-31 | -1.46 |
| 2021-12-31 | -0.53 |
| 2020-12-31 | -5.37 |
| 2019-12-31 | -0.80 |
| 2018-12-31 | -8.40 |
| 2017-12-31 | -1.62 |
